Treatment of experimental osteomyelitis by Methicillin Resistant Staphylococcus Aureus with bone cement system releasing grepafloxacin

Injury

Volumn 39, Issue 12, 2008, Pages 1384-1390

  Efstathopoulos, Nicolas ^a   Giamarellos Bourboulis, Evangellos ^a   Kanellakopoulou, Kyriaki ^a   Lazarettos, Ioannis ^a   Giannoudis, Peter ^b   Frangia, Konstantina ^c   Magnissalis, Evangellos ^d   Papadaki, Maria ^e   Nikolaou, Vassilios S ^a  

^a UNIVERSITY OF ATHENS   (Greece)

^b UNIVERSITY OF LEEDS   (United Kingdom)

^c SOTIRIA GENERAL HOSPITAL   (Greece)

^d Research Center for Biomaterials SA 15   (Greece)

^e AGIA OLGA HOSPITAL   (Greece)

Author keywords

Grepafloxacin; Local delivery system; MRSA; Osteomyelitis; PMMA

Indexed keywords

ACRYLIC CEMENT; GREPAFLOXACIN;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIMICROBIAL THERAPY; ARTICLE; BACTERIUM CULTURE; BIOMECHANICS; BONE MARROW; BONE RADIOGRAPHY; BONE STRUCTURE; CELL AGGREGATION; COMPRESSIVE STRENGTH; CONTROLLED STUDY; DEVICE REMOVAL; DISEASE COURSE; DRUG DELIVERY SYSTEM; DRUG EFFICACY; EXPERIMENTAL RABBIT; FEMUR; FOREIGN BODY; GRANULOMA; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; MICROBIOLOGICAL EXAMINATION; NONHUMAN; OSTEOBLAST; OSTEOMYELITIS; PRIORITY JOURNAL; REOPERATION; STAPHYLOCOCCUS INFECTION; TISSUE REACTION; YOUNG MODULUS;

ANIMALS; ANTI-BACTERIAL AGENTS; BONE CEMENTS; FLUOROQUINOLONES; METHICILLIN-RESISTANT STAPHYLOCOCCUS AUREUS; OSTEOMYELITIS; PIPERAZINES; PROSTHESIS-RELATED INFECTIONS; RABBITS; STAPHYLOCOCCAL INFECTIONS;

EID: 56949101884     PISSN: 00201383     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.injury.2008.04.006     Document Type: Article

References (50)

1. Adams K., Couch L., Cierny G., et al. In vitro and in vivo evaluation of antibiotic diffusion from antibiotic-impregnated polymethylmethacrylate beads. Clin Orthop Relat Res (1992) 244-252
2. Anguita-Alonso P., Hanssen A.D., Osmon D.R., et al. High rate of aminoglycoside resistance among staphylococci causing prosthetic joint infection. Clin Orthop Relat Res 439 (2005) 43-47
3. Anguita-Alonso P., Rouse M.S., Piper K.E., et al. Comparative study of antimicrobial release kinetics from polymethylmethacrylate. Clin Orthop Relat Res 445 (2006) 239-244
4. Buchholz H.W., Elson R.A., and Heinert K. Antibiotic-loaded acrylic cement: current concepts. Clin Orthop Relat Res (1984) 96-108
5. Buchholz H.W., and Engelbrecht H. Depot effects of various antibiotics mixed with Palacos resins. Chirurg 41 (1970) 511-515
6. Canadian Council on Animal Care C. Guide to the care and use of experimental animals, vol. 1; 1993.
7. Castro C., Evora C., Baro M., et al. Two-month ciprofloxacin implants for multibacterial bone infections. Eur J Pharm Biopharm 60 (2005) 401-406
8. Castro C., Sanchez E., Delgado A., et al. Ciprofloxacin implants for bone infection. In vitro-in vivo characterization. J Control Release 93 (2003) 341-354
9. Chodosh S., Lakshminarayan S., Swarz H., and Breisch S. Efficacy and safety of a 10-day course of 400 or 600 mg of grepafloxacin once daily for treatment of acute bacterial exacerbations of chronic bronchitis: comparison with a 10-day course of 500 mg of ciprofloxacin twice daily. Antimicrob Agents Chemother 42 (1998) 114-120
10. Cierny III G., Mader J.T., and Penninck J.J. A clinical staging system for adult osteomyelitis. Clin Orthop Relat Res (2003) 7-24
11. Clough G. The animal house: design, equipment and environmental control. In: Poole T.B. (Ed). UFAW (Universities Federation for Animal Welfare) handbook on the care and management of laboratory animals. 6th ed. (1986), Churchill Livingstone Inc., New York, NY 108-158
12. DiMaio F.R., O'Halloran J.J., and Quale J.M. In vitro elution of ciprofloxacin from polymethylmethacrylate cement beads. J Orthop Res 12 (1994) 79-82
13. Donati D., and Biscaglia R. The use of antibiotic-impregnated cement in infected reconstructions after resection for bone tumours. J Bone Joint Surg Br 80 (1998) 1045-1050
14. Eerenberg J.P., Patka P., Haarman H.J., and Dwars B.J. A new model for posttraumatic osteomyelitis in rabbits. J Invest Surg 7 (1994) 453-465
15. El-Kamel A.H., and Baddour M.M. Gatifloxacin biodegradable implant for treatment of experimental osteomyelitis: in vitro and in vivo evaluation. Drug Deliv 14 (2007) 349-356
16. Evans R.P., and Nelson C.L. Gentamicin-impregnated polymethylmethacrylate beads compared with systemic antibiotic therapy in the treatment of chronic osteomyelitis. Clin Orthop Relat Res (1993) 37-42
17. Fitzgerald Jr. R.H. Experimental osteomyelitis: description of a canine model and the role of depot administration of antibiotics in the prevention and treatment of sepsis. J Bone Joint Surg Am 65 (1983) 371-380
18. Garvin K.L., Miyano J.A., Robinson D., et al. Polylactide/polyglycolide antibiotic implants in the treatment of osteomyelitis. A canine model. J Bone Joint Surg Am 76 (1994) 1500-1506
19. Gerhart T.N., Roux R.D., Horowitz G., et al. Antibiotic release from an experimental biodegradable bone cement. J Orthop Res 6 (1988) 585-592
20. Gitelis S., and Brebach G.T. The treatment of chronic osteomyelitis with a biodegradable antibiotic-impregnated implant. J Orthop Surg (Hong Kong) 10 (2002) 53-60
21. GlaxoWellcome voluntarily withdraws raxar (grepafloxacin). Press release 1999; 2008.
22. Greene N., Holtom P.D., Warren C.A., et al. In vitro elution of tobramycin and vancomycin polymethylmethacrylate beads and spacers from Simplex and Palacos. Am J Orthop 27 (1998) 201-205
23. Gristina A.G., and Costerton J.W. Bacterial adherence to biomaterials and tissue. The significance of its role in clinical sepsis. J Bone Joint Surg Am 67 (1985) 264-273
24. Henry S.L., and Galloway K.P. Local antibacterial therapy for the management of orthopaedic infections. Pharmacokinetic considerations. Clin Pharmacokinet 29 (1995) 36-45
25. Kanellakopoulou K., Galanakis N., Giamarellos-Bourboulis E.J., et al. Treatment of experimental osteomyelitis caused by methicillin-resistant Staphylococcus aureus with a biodegradable system of lactic acid polymer releasing pefloxacin. J Antimicrob Chemother 46 (2000) 311-314
26. Klemm K. The use of antibiotic-containing bead chains in the treatment of chronic bone infections. Clin Microbiol Infect 7 (2001) 28-31
27. Klevens R.M., Edwards J.R., Tenover F.C., et al. Changes in the epidemiology of methicillin-resistant Staphylococcus aureus in intensive care units in US hospitals, 1992-2003. Clin Infect Dis 42 (2006) 389-391
28. Lazarettos J., Efstathopoulos N., Papagelopoulos P.J., et al. A bioresorbable calcium phosphate delivery system with teicoplanin for treating MRSA osteomyelitis. Clin Orthop Relat Res (2004) 253-258
29. Lode H., Vogel F., and Elies W. Grepafloxacin: a review of its safety profile based on clinical trials and postmarketing surveillance. Clin Ther 21 (1999) 61-74 discussion 1-2
30. Nakajima Y., Hattori K., Shinsei M., et al. Physiologically-based pharmacokinetic analysis of grepafloxacin. Biol Pharm Bull 23 (2000) 1077-1083
31. National Nosocomial Infections Surveillance (NNIS) System report, data summary from January 1990 to May 1999, issued June 1999. Am J Infect Control 1999;27:520-32.
32. Neut D., van de Belt H., Stokroos I., et al. Biomaterial-associated infection of gentamicin-loaded PMMA beads in orthopaedic revision surgery. J Antimicrob Chemother 47 (2001) 885-891
33. Norden C.W. Experimental osteomyelitis. I. A description of the model. J Infect Dis 122 (1970) 410-418
34. Owens Jr. R.C., and Ambrose P.G. Torsades de pointes associated with fluoroquinolones. Pharmacotherapy 22 (2002) 663-668 discussion 8-72
35. Ozaki T., Yoshitaka T., Kunisada T., et al. Vancomycin-impregnated polymethylmethacrylate beads for methicillin-resistant Staphylococcus aureus (MRSA) infection: report of two cases. J Orthop Sci 3 (1998) 163-168
36. Pankuch G.A., Jacobs M.R., and Appelbaum P.C. Activity of CP 99,219 compared with DU-6859a, ciprofloxacin, ofloxacin, levofloxacin, lomefloxacin, tosufloxacin, sparfloxacin and grepafloxacin against penicillin-susceptible and -resistant pneumococci. J Antimicrob Chemother 35 (1995) 230-232
37. Panlilio A.L., Culver D.H., Gaynes R.P., et al. Methicillin-resistant Staphylococcus aureus in U.S. hospitals, 1975-1991. Infect Control Hosp Epidemiol 13 (1992) 582-586
38. Rothlin R.P. Quinolones: historic review. Medicina (B Aires) 59 Suppl. 1 (1999) 3-7
39. Sader H.S., Erwin M.E., and Jones R.N. In vitro activity of OPC-17116 compared to other broad-spectrum fluoroquinolones. Eur J Clin Microbiol Infect Dis 11 (1992) 372-381
40. Sasaki S., and Ishii Y. Apatite cement containing antibiotics: efficacy in treating experimental osteomyelitis. J Orthop Sci 4 (1999) 361-369
41. Schulz S., Steinhart H., and Mutters R. Chronic osteomyelitis in a new rabbit model. J Invest Surg 14 (2001) 121-131
42. Stahlmann R., and Lode H. Toxicity of quinolones. Drugs 58 Suppl. 2 (1999) 37-42
43. The European Antimicrobial Resistance Surveillance System (EARSS), Annual report; 2006.
44. van de Belt H., Neut D., Schenk W., et al. Gentamicin release from polymethylmethacrylate bone cements and Staphylococcus aureus biofilm formation. Acta Orthop Scand 71 (2000) 625-629
45. Wahlig H., Dingeldein E., Bergmann R., and Reuss K. The release of gentamicin from polymethylmethacrylate beads. An experimental and pharmacokinetic study. J Bone Joint Surg Br 60-B (1978) 270-275
46. Wakebe H., Imada T., Yoneda H., et al. Evaluation of OPC-17116 against important pathogens that cause respiratory tract infections. Antimicrob Agents Chemother 38 (1994) 2340-2345
47. Walenkamp G.H., Kleijn L.L., and de Leeuw M. Osteomyelitis treated with gentamicin-PMMA beads: 100 patients followed for 1-12 years. Acta Orthop Scand 69 (1998) 518-522
48. Whitener C.J., Park S.Y., Browne F.A., et al. Vancomycin-resistant Staphylococcus aureus in the absence of vancomycin exposure. Clin Infect Dis 38 (2004) 1049-1055
49. Wiedemann B., and Heisig P. Antibacterial activity of grepafloxacin. J Antimicrob Chemother 40 Suppl. A (1997) 19-25
50. Witte W. Antibiotic resistance in gram-positive bacteria: epidemiological aspects. J Antimicrob Chemother 44 Suppl. A (1999) 1-9